Form 4: Macrogenics Director Meenu Chhabra Reports Stock and Option Awards

Director Meenu Chhabra reported the acquisition of restricted stock units and stock options in Macrogenics Inc. on May 21, 2024.

Summary

• On May 21, 2024, Meenu Chhabra, a director of Macrogenics Inc., reported transactions involving the company's securities.
• Chhabra acquired 6,500 restricted stock units (RSUs), each representing a contingent right to receive one share of Macrogenics' common stock.
• These RSUs will vest one year after the grant date or the day before the next annual meeting, whichever is earlier.
• Chhabra also acquired stock options to purchase 16,500 shares of common stock at an exercise price of $4.26.
• Additionally, Chhabra acquired stock options to purchase 17,077 shares of common stock at an exercise price of $3.66, issued in lieu of direct cash compensation.
• Both sets of options vest in monthly increments over one year from the grant date and expire on May 21, 2034.
• Following these transactions, Chhabra directly owns 6,500 RSUs, 16,500 stock options with an exercise price of $4.26, and 17,077 stock options with an exercise price of $3.66.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option awards to a director. While insider ownership is generally viewed positively, this is a standard compensation practice.

Positives

• The acquisition of stock options and restricted stock units by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key individuals within a company.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment due to increased insider ownership.

Key Dates